Akamai Technologies vs Cloudflare
AKAM and NET side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AKAM and NET compare
Cloudflare is the larger company, worth 8.9 times as much as Akamai Technologies ($109B against $12.3B).
Cloudflare grew revenue faster over the last twelve months (35.7% versus 6.2% for Akamai Technologies).
Akamai Technologies keeps more of each dollar of sales as profit, with a net margin of 8.8% compared with −8.7% at Cloudflare.
Akamai Technologies scores higher on the StockData Score (11 against 9 for Cloudflare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AKAM | NET |
|---|---|---|
| Size and price | ||
| Market cap | $12.3B | $109B |
| Share price | $85.40 | $305.81 |
| Change, 1 year | −5.2% | 35.5% |
| Change, 5 years | −23.0% | 44.9% |
| Beta (5Y) | 0.86 | 2.30 |
| Employees | 11K | 5,156 |
| StockData Score | ||
| Total score | 11 (better) | 9 |
| Valuation score | 3 (better) | 0 |
| Growth score | 0 | 3 (better) |
| Performance score | 3 (better) | 1 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 33.1× | – |
| P/S | 2.8× (better) | 39.8× |
| P/B | 2.4× (better) | 74.3× |
| EV/EBITDA | 7.7× | – |
| P/FCF | 22.5× (better) | 303× |
| FCF yield | 4.4% (better) | 0.33% |
| Fair value | $93.76 | $77.67 |
| Margin of safety | 8.9% (better) | −294% |
| Growth | ||
| Revenue growth (TTM) | 6.2% | 35.7% (better) |
| Revenue growth, 5Y average | 5.6% | 38.1% (better) |
| Net income growth (TTM) | −23.5% | – |
| EPS growth (TTM) | −24.3% | – |
| EPS growth, 5Y average | −1.8% | – |
| Profitability | ||
| Gross margin | 56.4% | 71.9% (better) |
| Operating margin | 9.1% (better) | −14.1% |
| Net margin | 8.8% (better) | −8.7% |
| FCF margin | 12.4% | 13.2% (better) |
| Return on equity | 7.9% (better) | −17.0% |
| Return on invested capital | 12.7% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | 11.1× (better) | −31.8× |
| Current ratio | 2.13 | 3.80 (better) |
| Altman Z-score | 1.61 | 11.08 (better) |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Buyback yield | 5.0% | – |
| Shareholder yield | 5.0% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 111% | 79.9% |
| Held by insiders | 2.2% | 8.1% |
| Insider net buying, 12 months | −$16.1M (better) | −$638M |
| Short interest, % of float | 13.6% | 2.4% |
Go deeper
- AKAM stock overview
- AKAM income statement
- AKAM valuation and score
- NET stock overview
- NET income statement
- NET valuation and score
Other comparisons
- AKAM vs ALLE
- CRWD vs NET
- DBX vs NET
- DDOG vs NET
- DT vs NET
- GEN vs NET
- MDB vs NET
- NET vs OKTA
- NET vs RBLX
- NET vs TWLO
- NET vs YOU
- NET vs ZS
For information only, not investment advice. Check the source filings before relying on any figure.